These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 30815157)
41. Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data. Adeli E; Shi F; An L; Wee CY; Wu G; Wang T; Shen D Neuroimage; 2016 Nov; 141():206-219. PubMed ID: 27296013 [TBL] [Abstract][Full Text] [Related]
42. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset. Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359 [TBL] [Abstract][Full Text] [Related]
43. The Future of Brain Imaging in Parkinson's Disease. Helmich RC; Vaillancourt DE; Brooks DJ J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163 [TBL] [Abstract][Full Text] [Related]
44. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis. Bhat S; Acharya UR; Hagiwara Y; Dadmehr N; Adeli H Comput Biol Med; 2018 Nov; 102():234-241. PubMed ID: 30253869 [TBL] [Abstract][Full Text] [Related]
45. Brain connectivity for subtypes of parkinson's disease using structural MRI. Samantaray T; Saini J; Pal PK; Gupta CN Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38224618 [No Abstract] [Full Text] [Related]
46. Classification of the Multiple Stages of Parkinson's Disease by a Deep Convolution Neural Network Based on Hsu SY; Yeh LR; Chen TB; Du WC; Huang YH; Twan WH; Lin MC; Hsu YH; Wu YC; Chen HY Molecules; 2020 Oct; 25(20):. PubMed ID: 33086589 [TBL] [Abstract][Full Text] [Related]
47. Hi-GCN: A hierarchical graph convolution network for graph embedding learning of brain network and brain disorders prediction. Jiang H; Cao P; Xu M; Yang J; Zaiane O Comput Biol Med; 2020 Dec; 127():104096. PubMed ID: 33166800 [TBL] [Abstract][Full Text] [Related]
57. Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers. He P; Gao Y; Shi L; Li Y; Jiang S; Tie Z; Qiu Y; Ma G; Zhang Y; Nie K; Wang L Neurosci Lett; 2023 Sep; 814():137435. PubMed ID: 37562710 [TBL] [Abstract][Full Text] [Related]
58. CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report. Gao R; Zhang G; Chen X; Yang A; Smith G; Wong DF; Zhou Y PLoS One; 2016; 11(10):e0164762. PubMed ID: 27764160 [TBL] [Abstract][Full Text] [Related]
59. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease. Spasov S; Passamonti L; Duggento A; Liò P; Toschi N; Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174 [TBL] [Abstract][Full Text] [Related]
60. PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies. Berman SB; Miller-Patterson C Prog Mol Biol Transl Sci; 2019; 165():167-185. PubMed ID: 31481162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]